Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Check Point Software Technologies Ltd (CHKP) vs Revvity Inc (RVTY) Price & Performance

Check Point Software Technologies LtdTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Check Point Software Technologies Ltd vs Revvity Inc — how do they compare? Check Point Software Technologies Ltd trades at $129.5 (market cap $13.18B), while Revvity Inc trades at $117.6 (market cap $12.91B). The key difference: Check Point Software Technologies Ltd and Revvity Inc are close in size by market cap, and Revvity Inc pays a 0.24% dividend while Check Point Software Technologies Ltd pays none. Which is the better fit depends on your goals.

CHKPRVTY
Market Cap
$13.18B$12.91B
Sector
TechnologyTechnology
52-Week High
$206.91$117.75
52-Week Low
$112.47$82.26
Enterprise Value
$12.88B$15.23B
Dividend Yield
0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Check Point Software Technologies Ltd

CHKP trades at $129.29, down 1.41% today, with a bearish technical signal as it hovers near support at $128. The stock shows strong fundamentals with a P/E of 13.24, net income margin of 37.93%, and consistent earnings beats in recent quarters. Recent news highlights AI security growth potential and insider selling activity.

The outlook is mixed: valuation appears attractive with a consensus price target of $146.92, but near-term risks include competitive pressures and margin declines. Upside depends on AI-driven revenue acceleration in 2027, while downside is capped by solid cash flow and profitability.

Revvity Inc

RVTY trades at $117.88, up 1.6% today, with a bullish technical outlook and strong earnings momentum after beating Q2 2026 EPS estimates. The stock is near the consensus price target of $120.50, supported by a 51.72% analyst buy rating. Recent news highlights product launches like the SuperFlex prenatal system and investor conference participation, reinforcing growth prospects in diagnostics and biotech tools.

The outlook remains positive with revenue stability and margin strength, but elevated P/E of 55.64 poses valuation risk. Key opportunities include diagnostic demand and AI-driven workflows, while risks involve competitive pressures and execution challenges. Net cash flow turned positive in 2026, signaling improved financial health.

Returns comparison

Trailing returns across standard periods

About Check Point Software Technologies Ltd

Check Point is a global leader in cybersecurity solutions. It provides comprehensive protection against advanced cyber threats for corporate networks, cloud environments, mobile devices, and critical infrastructure.

Read more on CHKP

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY